Oral ibandron- ate reduces the risk of skeletal complications in breast cancer patients with with metastatic bone disease; results from two randomized, placebocontrolled phase III studies. - Body, JJ; Diel, IJ; Lichinitser, M (Br J Cancer, 2004)
et al.